Fintel reports that on March 21, 2025, Maxim Group initiated coverage of Anixa Biosciences (NasdaqCM:ANIX) with a Buy ...
Anixa Biosciences (ANIX) announced has it has dosed its final patient in the third cohort of its ongoing Phase 1 clinical trial evaluating its ...